首页> 美国卫生研究院文献>International Journal of Oncology >microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R
【2h】

microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R

机译:microRNA-194通过靶向CDH2和IGF1R在体外和体内抑制骨肉瘤细胞的增殖和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Studies have shown that miR-194 functions as a tumor suppressor and is associated with tumor growth and metastasis. We studied the effects of miR-194 in osteosarcoma and the possible mechanism by which miR-194 affected the survival, apoptosis and metastasis of osteosarcoma. Both human osteosarcoma cell lines SOSP-9607 and U2-OS were transfected with recombinant lentiviruses to regulate miR-194 expression. Overexpression of miR-194 partially inhibited the proliferation, migration, and invasion of osteosarcoma cells in vitro, as well as tumor growth and pulmonary metastasis of osteosarcoma cells in vivo. Potential miR-194 target genes were predicted using bioinformatics. Luciferase reporter assay, real-time quantitative PCR and western blotting confirmed that CDH2 (N-cadherin) and IGF1R were targets of miR-194. Using real-time quantitative PCR, we evaluated the expression of miR-194 and two miR-194 target genes, CDH2 and IGF1R in osteosarcoma samples from 107 patients and 99 formalin- or paraformalin-fixed paraffin-embedded tissues. The expressions of the target genes were also examined in osteosarcoma samples using immunohistochemistry. Overexpression of miR-194 inhibited tumor growth and metastasis of osteosarcoma probably by downregulating CDH2 and IGF1R. miR-194 may prove to be a promising therapeutic agent for osteosarcoma.
机译:研究表明,miR-194起到抑癌作用,并与肿瘤的生长和转移有关。我们研究了miR-194在骨肉瘤中的作用以及miR-194影响骨肉瘤生存,凋亡和转移的可能机制。用重组慢病毒转染人骨肉瘤细胞系SOSP-9607和U2-OS,以调节miR-194的表达。 miR-194的过表达在体外部分抑制骨肉瘤细胞的增殖,迁移和侵袭,以及在体内抑制骨肉瘤细胞的肿瘤生长和肺转移。使用生物信息学预测了潜在的miR-194靶基因。荧光素酶报告基因测定,实时定量PCR和Western印迹证实CDH2(N-钙粘着蛋白)和IGF1R是miR-194的靶标。使用实时定量PCR,我们评估了107例患者和99个福尔马林或多聚福尔马林固定的石蜡包埋组织的骨肉瘤样品中miR-194和两个miR-194靶基因CDH2和IGF1R的表达。还使用免疫组织化学检查了骨肉瘤样品中靶基因的表达。 miR-194的过表达可能通过下调CDH2和IGF1R抑制肿瘤的生长和骨肉瘤的转移。 miR-194可能被证明是骨肉瘤的有前途的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号